Improvements in childhood and adolescent cancer mortality and survival rates have continued in recent years, but the rate of progress has been greater in hematologic malignances than in solid tumors. A short reflection on these achievements is warranted before quickly turning our attention to the remaining challenges.
No takes yet. Share an insight, caveat, or question.
Pritchard‐Jones et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: